Skip to main content
See every side of every news story
Published loading...Updated

Beam Therapeutics (NASDAQ:BEAM) Insider Christine Bellon Sells 5,956 Shares

Summary by defenseworld.net
Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) insider Christine Bellon sold 5,956 shares of Beam Therapeutics stock in a transaction on Wednesday, April 1st. The stock was sold at an average price of $24.58, for a total value of $146,398.48. Following the sale, the insider owned 109,711 shares in the company, valued at $2,696,696.38. The trade was a 5.15% decrease in their ownership of the stock. The transaction was disclosed in a docum…

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

tickerreport.com broke the news in on Monday, April 6, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal